1. Home
  2. PDLB vs DCTH Comparison

PDLB vs DCTH Comparison

Compare PDLB & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDLB
  • DCTH
  • Stock Information
  • Founded
  • PDLB 1960
  • DCTH 1988
  • Country
  • PDLB United States
  • DCTH United States
  • Employees
  • PDLB N/A
  • DCTH N/A
  • Industry
  • PDLB
  • DCTH Medical/Dental Instruments
  • Sector
  • PDLB
  • DCTH Health Care
  • Exchange
  • PDLB Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • PDLB 328.3M
  • DCTH 388.3M
  • IPO Year
  • PDLB 2017
  • DCTH N/A
  • Fundamental
  • Price
  • PDLB $14.76
  • DCTH $11.20
  • Analyst Decision
  • PDLB
  • DCTH Strong Buy
  • Analyst Count
  • PDLB 0
  • DCTH 4
  • Target Price
  • PDLB N/A
  • DCTH $24.50
  • AVG Volume (30 Days)
  • PDLB 28.1K
  • DCTH 493.0K
  • Earning Date
  • PDLB 10-29-2025
  • DCTH 11-07-2025
  • Dividend Yield
  • PDLB N/A
  • DCTH N/A
  • EPS Growth
  • PDLB 83.78
  • DCTH N/A
  • EPS
  • PDLB 0.71
  • DCTH 0.06
  • Revenue
  • PDLB $90,513,000.00
  • DCTH $70,240,000.00
  • Revenue This Year
  • PDLB $10.97
  • DCTH $159.22
  • Revenue Next Year
  • PDLB $8.59
  • DCTH $42.78
  • P/E Ratio
  • PDLB $20.81
  • DCTH $201.97
  • Revenue Growth
  • PDLB 15.50
  • DCTH 491.35
  • 52 Week Low
  • PDLB $10.88
  • DCTH $8.08
  • 52 Week High
  • PDLB $15.21
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • PDLB 53.05
  • DCTH 51.88
  • Support Level
  • PDLB $14.66
  • DCTH $10.61
  • Resistance Level
  • PDLB $14.96
  • DCTH $11.38
  • Average True Range (ATR)
  • PDLB 0.21
  • DCTH 0.46
  • MACD
  • PDLB -0.04
  • DCTH 0.02
  • Stochastic Oscillator
  • PDLB 25.00
  • DCTH 45.11

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: